Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 14.35
-0.15 (-1.03%)
At close: Aug 18, 2026
Genomics BioSci & Tech. Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 718.16 | 708.38 | 517.58 | 396.14 | 419 | 389.97 |
Revenue Growth | 27.54% | 36.86% | 30.65% | -5.46% | 7.45% | -12.01% |
Gross Profit Gross Profit Growth | 202.65 | 231.36 | 157.18 | 119.91 | 136.01 | 109.92 |
Operating Income Operating Income Growth | -129.52 | -84.16 | -140.29 | -81.9 | -33.52 | -28.66 |
Net Income Net Income Growth | -25.7 | -39.43 | -223.1 | -168.07 | 71.6 | 18.74 |
Earnings Per Share EPS Growth | -0.35 | -0.54 | -3.08 | -2.36 | 1.13 | 0.31 |
EPS Growth | - | - | - | - | 267.48% | 3103.13% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Instrument Sales Department Instrument Sales Department Growth | 191.92 | - | - | - | - |
Genetic Testing Department Genetic Testing Department Growth | 519.86 | 517.58 | 397.18 | 419 | 389.97 |
Adjustment and Eliminations Adjustment and Eliminations Growth | -3.4 | - | -1.03 | - | - |
Total Total Growth | 708.38 | 517.58 | 396.14 | 419 | 389.97 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 210.46 | 172.9 | 237.58 | 253.03 | 317 | 107.5 |
Total Debt Total Debt Growth | 475.23 | 628.25 | 507.67 | 283.61 | 228.84 | 86.53 |
Net Cash (Debt) Net Cash Growth | -264.77 | -455.35 | -270.08 | -30.58 | 88.17 | 20.96 |
Net Cash Growth | - | - | - | - | 320.57% | -95.42% |
Net Cash Per Share Net Cash Per Share Growth | -3.63 | -6.29 | -3.73 | -0.43 | 1.39 | 0.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -68.87 | -86.79 | -111.77 | -96.02 | -21.13 | -27.76 |
Capital Expenditures CapEx Growth | -35.89 | -73.49 | -193.62 | -150.26 | -94.08 | -93.59 |
Free Cash Flow Free Cash Flow Growth | -104.76 | -160.28 | -305.39 | -246.28 | -115.21 | -121.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.22% | 32.66% | 30.37% | 30.27% | 32.46% | 28.19% |
Operating Margin | -18.04% | -11.88% | -27.11% | -20.67% | -8.00% | -7.35% |
Pretax Margin | -7.74% | -9.55% | -45.47% | -42.39% | 17.25% | 3.10% |
Profit Margin | -3.58% | -5.57% | -43.10% | -42.43% | 17.09% | 4.81% |
FCF Margin | -14.59% | -22.63% | -59.00% | -62.17% | -27.50% | -31.12% |
| Fiscal Year | FY 2022 |
|---|---|
| Period Ending | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.098 |
Dividend Per Share Growth | - |
Dividend Yield | 0.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 17.56 | 60.09 |
PS Ratio | 1.45 | 2.63 | 2.69 | 3.80 | 3.00 | 2.89 |